while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain..
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..